AGP Picks
View all

Northern Mariana Islands Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Northern Mariana Islands Health News.

Press releases published on May 27, 2026

20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
Altimmune to Participate in Upcoming Investor Conferences
EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients
TOMI Environmental Solutions Highlights Expanded Market Opportunity Following CDC-Published Hantavirus Study and Rising Global Ebola Concerns
Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development
PREMIA and Lind Form Lind Asia to Expand AI-Powered Clinical Trial Screening Across Asia-Pacific
Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences
Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference
Collegium to Participate in 2026 Jefferies Global Healthcare Conference
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
ViroMissile IDOV-Safe Phase 1 Data to Be Presented at the 2026 ASCO Annual Meeting
Avalyn to Participate in the Jefferies Global Healthcare Conference
Annexon to Participate in Upcoming June Investor Conferences
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
4DMT to Participate in Upcoming Investor Conferences
Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis

Share this page:

Sign up for:

Northern Mariana Islands Health News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.